Adia Med Finalizing In-Network Access With The Nation's Largest Health Insurers Including Medicare, Medicaid, Humana, Cigna, And Florida Blue

(MENAFN- Newsfile Corp) Winter Park, Florida--(Newsfile Corp. - September 2, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in regenerative medicine, is thrilled to announce a transformative step toward expanding patient access to its innovative stem cell therapies. The company is finalizing in-network provider status with some of the nation's largest health insurance providers-Humana, Florida Blue, Cigna, Medicare, and Medicaid-positioning Adia to bring its advanced treatments to millions of patients.

Expanding Access to Revolutionary Care
Adia Nutrition is making significant progress in securing in-network status, a critical move to make its regenerative therapies more accessible and affordable. Current developments include:

• Humana: Application submitted, awaiting response.
• Florida Blue: Process initiated, provider numbers in progress.
• Cigna: Application submitted, response pending.
• Medicare: Access pending, actively in progress.
• Medicaid: Access pending, actively in progress.

This milestone will enhance Adia's ability to deliver its therapies, including those for widely covered treatments like wound repair, to a broader patient base, building on its recent partnership with the PI Doctors Elite Community, connecting Adia Labs with over 4,000 personal injury physicians nationwide.

A Vision for Accessible Healing
"Joining these major insurance networks will open doors for countless patients to experience our regenerative therapies," said Larry Powalisz, CEO of Adia Nutrition Inc. "We're excited to make this a reality, helping people heal and growing value for our investors."

Join the Regenerative Revolution
Adia Nutrition is dedicated to transforming healthcare by making regenerative solutions more accessible. Stay tuned for updates as we advance toward in-network approval with these major insurers.

MENAFN02092025004218003983ID1110008229